UNITED THERAPEUTICS Corp (UTHR) › Shares OutstandingUNITED THERAPEUTICS Corp (UTHR) — Shares OutstandingAnnual figures by period end, from SEC filings.2009-12-31: 54.22M2010-12-31: 57.56M2011-12-31: 53.61M2012-12-31: 50.17M2013-12-31: 50.39M2014-12-31: 47.11M2015-12-31: 45.76M2016-12-31: 42.97M2017-12-31: 43.24M2018-12-31: 43.59M2019-12-31: 43.88M2020-12-31: 44.51M2021-12-31: 45.11M2022-12-31: 46.03M2023-12-31: 47.04M2024-12-31: 44.83M2025-12-31: 43.64M43.64M2009-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-3143.64M-2.7%2026-02-25Balance as of period end2024-12-3144.83M-4.7%2026-02-25Balance as of period end2023-12-3147.04M+2.2%2025-02-26Balance as of period end2022-12-3146.03M+2.0%2024-02-21Balance as of period end2021-12-3145.11M+1.3%2023-02-22Balance as of period end2020-12-3144.51M+1.4%2022-02-24Balance as of period end2019-12-3143.88M+0.7%2021-02-24Balance as of period end2018-12-3143.59M+0.8%2020-02-26Balance as of period end2017-12-3143.24M+0.6%2019-02-27Balance as of period end2016-12-3142.97M-6.1%2018-02-21Balance as of period end2015-12-3145.76M-2.9%2017-02-22Balance as of period end2014-12-3147.11M-6.5%2016-02-25Balance as of period end2013-12-3150.39M+0.4%2015-02-24Balance as of period end2012-12-3150.17M-6.4%2014-02-25Balance as of period end2011-12-3153.61M-6.9%2013-02-26Balance as of period end2010-12-3157.56M+6.2%2012-02-28Balance as of period end2009-12-3154.22M—2011-02-24Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)